Cargando…

Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers

BACKGROUND: Primary stroke centers (PSCs) utilize more recombinant tissue plasminogen activator (rt‐PA) than non‐PSCs. The impact of PSCs on racial disparities in rt‐PA use is unknown. METHODS AND RESULTS: We used data from the Nationwide Inpatient Sample from 2004 to 2010, limited to states that pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aparicio, Hugo J., Carr, Brendan G., Kasner, Scott E., Kallan, Michael J., Albright, Karen C., Kleindorfer, Dawn O., Mullen, Michael T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845141/ https://www.ncbi.nlm.nih.gov/pubmed/26467999 http://dx.doi.org/10.1161/JAHA.115.001877

Ejemplares similares

Joint Commission Primary Stroke Centers Utilize More rt‐PA in the Nationwide Inpatient Sample
por: Mullen, Michael T., et al.
Publicado: (2013)

Sex Differences in rt-PA Utilization at Hospitals Treating Stroke: The National Inpatient Sample
por: Boehme, Amelia K., et al.
Publicado: (2017)

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2016)

Predictors of Intracerebral Hemorrhage in Acute Stroke Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator
por: Chenna, Vijay, et al.
Publicado: (2018)

Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis
por: You, Shoujiang, et al.
Publicado: (2018)

Persistent racial disparities in cervical cancer screening with Pap test
por: McDaniel, Cassidi C., et al.
Publicado: (2021)

Persistent Racial Disparities in Deep Brain Stimulation for Parkinson's Disease
por: Cramer, Samuel W., et al.
Publicado: (2022)

Vaccination intentions generate racial disparities in the societal persistence of COVID-19
por: Wang, Yanchao, et al.
Publicado: (2021)

Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
por: Hong, Keun-Sik, et al.
Publicado: (2009)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?
por: Almasi, Mostafa, et al.
Publicado: (2016)

Carotid Artery Stenting for Acute Ischemic Stroke Patients after Intravenous Recombinant Tissue Plasminogen Activator Treatment
por: Deguchi, Ichiro, et al.
Publicado: (2016)

Age-specific Cost Effectiveness of Using Intravenous Recombinant Tissue Plasminogen Activator for Treating Acute Ischemic Stroke
por: Joo, Heesoo, et al.
Publicado: (2017)

A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischaemic stroke
por: Joo, Heesoo, et al.
Publicado: (2017)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

Pockets of progress amidst persistent racial disparities in low birthweight rates
por: Goldfarb, Samantha S., et al.
Publicado: (2018)

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients over 80 Years Old: The Fukuoka Stroke Registry
por: Matsuo, Ryu, et al.
Publicado: (2014)

Emergent Double-barrel Bypass Shortly after Intravenous Administration of Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
por: Choi, Joon-Ho, et al.
Publicado: (2016)

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
por: Shibata, Soichiro, et al.
Publicado: (2022)

Racial disparities in access to alternative donor allografts persist in the era of “donors for all”
por: Fingrut, Warren B., et al.
Publicado: (2022)

Homocystinuria with Cerebral Venous Sinus Thrombosis: Excellent Recovery with Intravenous Recombinant Tissue Plasminogen Activator
por: Gowda, Vykuntaraju K, et al.
Publicado: (2017)

Association of Prediabetes and Diabetes With Stroke Symptoms : The REasons for Geographic And Racial Differences in Stroke (REGARDS) study
por: Carson, April P., et al.
Publicado: (2012)

Persistent socioeconomic and racial and ethnic disparities in pathogen burden in the United States, 1999–2014
por: Stebbins, R. C., et al.
Publicado: (2019)

Racial Disparities in Prostate Cancer Stage at Diagnosis Persist Despite Community Affluence
por: Nemesure, Barbara, et al.
Publicado: (2022)

Racial Disparities of Adrenalectomy
por: Holoubek, Simon A, et al.
Publicado: (2020)

Racial disparities in dermatology
por: Narla, Shanthi, et al.
Publicado: (2022)

Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis
por: Li, Xueyuan, et al.
Publicado: (2023)

Blood Pressure Control in Diabetes: Temporal progress yet persistent racial disparities: national results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
por: Cummings, Doyle M., et al.
Publicado: (2010)

Factors contributing to racial disparities in influenza vaccinations
por: Vupputuri, Suma, et al.
Publicado: (2019)

Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome
por: Kounis, Nicholas G., et al.
Publicado: (2011)

Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
por: Essig, Fabian, et al.
Publicado: (2021)

N‐Terminal pro‐B‐type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort
por: Landry, Kara K., et al.
Publicado: (2020)

Trajectories in health in late midlife: disparities persist across racial/ethnic groups in US
por: Doza, Adit, et al.
Publicado: (2020)

Outcomes of Endovascular Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator for the Treatment of Vertebrobasilar Stroke
por: Brinjikji, Waleed, et al.
Publicado: (2014)

Addressing racial and ethnic disparities in US liver cancer care
por: Kim, Nicole J., et al.
Publicado: (2023)

The Potential of Telecommunication Technology to Address Racial/Ethnic Disparities in HIV PrEP Awareness, Uptake, Adherence, and Persistence in Care: A Review
por: Evans, Kimberly N., et al.
Publicado: (2022)

Age and Sex Disparities in Discharge Statin Prescribing in the Stroke Belt: Evidence From the Reasons for Geographic and Racial Differences in Stroke Study
por: Albright, Karen C., et al.
Publicado: (2017)

Racial Disparity in the Treatment of Aortic Stenosis
por: Edelman, J. James, et al.
Publicado: (2021)

A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy
por: Shirazy, Mohamed, et al.
Publicado: (2019)

Racial Disparities in Surgical Treatment of Obstructive Sleep Apnea
por: Cohen, Samuel M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k11cs893fv0s7krn9d8emdroii